| Diclofenac Potassium | ASSERTIO Therapeutics | ||
| 25mg; Capsule, Oral |
Less Than $1000 mn
|
||
|
Less Than 5
|
Less Than 5
|
||
| None | None | ||
|
Less Than 5
|
Less Than 5
|
||
| Used to treat mild to moderate acute pain in adults | |||
|
Yes
| |||
| Zipsor | Patent 1 | Patent 2 | Patent 3 | Patent 4 | Patent 5 | Patent 6 | Patent 7 |
|---|---|---|---|---|---|---|---|
| ****** | ******* | ******* | ******* | ******* | ******* | ******* | ******* |
| ******* | ******* | ******* | ******* | ******* | ******* | ******* | ******* |
| Company | FTF Status / 180 days exclusivity | 30-Months stay | Current Litigation Status | Current Approval Status | Likelihood of launch |
|---|---|---|---|---|---|
| ****** | *** \ ** | *** **, **** | ******* | ******** | ******** ** ***** **, **** |
| ******* | ** \ ** | *** *, **** | ******* | ******** ************ | *** *** ****** |
Download ParaIV Report